logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Stock market anomaly: Gali Pharmaceutical-B (01672.HK) jumped more than 7% in early trading, the company will announce the results of early research on obesity candidate drug ASC47.

date
09/05/2025
According to the iFast Financial APP, Ge Li Pharmaceutical-B (01672.HK) rose more than 7% in early trading, as of the publication, up by 6.15%, at 7.08 Hong Kong dollars, with a trading volume of 13.33 million Hong Kong dollars.
Latest
1 m ago
Great Northern Farm: 601,100 pigs were sold in April, with sales revenue reaching 1.009 billion yuan.
2 m ago
Central Bank: Pay attention to the changes in government bond yields and resume operations based on market supply and demand conditions.
2 m ago
Sino-Thai: Resourceful Integrated Utilization Demonstration Project for Upgrading Methanol Successfully Passes Trial Production.
2 m ago
Federal Reserve Governor Bostic: Tariffs will lead to a slowdown in the economy, thus causing higher unemployment rates, which I am equally concerned about. Tariffs may disrupt supply chains and continue to exert upward pressure on inflation.
3 m ago
Hengrui Medicine (600276.SH): SHR-1316 (sc) Injection receives drug clinical trial approval notification.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.